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Highlights: 
 Advanced wound dressings account for over 60% of sales in a market worth 
$11.4 billion annually  
 Increased cases of diabetes worldwide and diabetic ulcers is key driving 
factor for the growth of this industry 
 Hydrogels are an innovative  type of dressing which uses moisture to aid the 
healing process 
 Our focus is preparation methods, wound products and material aspect of 
hydrogel dressings. 
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Abstract 
Wound treatment has gained huge impact in the wound care sector due to the 
pervasiveness of chronic wounds in the high risk population including, but not limited 
to, geriatric population, immunocompromised and obese patients. Rising prevalence 
of diabetes is another leading factor of the growth in chronic wound. According to the 
World Health Organization (WHO), the global diabetic prevalence has increased 
from 4.7% in 1980 to 8.5% in 2014. Moreover, according to the National Institute for 
Health and Care Excellence (NICE), in 2016, the prevalence of chronic venous leg 
ulcers alone was around 0.1% to 0.3% in the U.K. Wound dressings play an 
imperative role in wound healing process as they protect the wound site from 
external environment and are capable of interacting with the wound bed to facilitate 
and accelerate healing. Hence, the demand for advanced wound dressing products 
is rising. Advanced wound care that hydrogel wound dressings form part of, make up 
around $7.1 billion of the market and they are growing at an annual rate of 8.3% with 
the market projected to be worth $12.5 billion by 2022. Hydrogels, due to high water 
content, are ideal candidates for wound management as advanced moist dressings 
for wound healing. These wound dressing materials can be used for both: exudating 
or dry necrotic wounds. Additionally, hydrogels demonstrate other important features 
such as softness, malleability and biocompatibility. Presented review focuses on 
hydrogel wound dressings, their main characteristics and their wound management 
applications. It also describes recent technologies used for their production and the 
future potential developments.  
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1. Introduction 
A wound is an injury that disrupts the integrity of the epidermis as a physical barrier 
thereby interrupting its normal anatomical structure and physiology [1]. Dermal injury 
can be caused by acute trauma or surgical event. The resultant damage can affect 
local epidermal tissue, the vascular network and depending on the nature and depth 
of the wound, dermal intricate structure may also get damaged. In the case of 
surgical incisions, as the tissue loss is minimal and the healing process is rapid, 
wounds can be closed by variety of techniques including adhesive strips, sutures or 
skin adhesives (closure by primary intention) unless there is any underlying 
pathological condition hindering the healing process. In the case of acute trauma 
associated with substantial dermal matrix loss, closure by secondary intention, 
allowing the defect to be filled with granulation tissue is the primary approach 
followed for repair process. Reparative process is protracted when the defect area is 
large due to increased demand for production of dermal matrix forming cells for 
healing [2].  
Wound healing is a complex biological process that varies in completeness and 
length of time to resolution depending on whether the wound is acute or chronic [3]. 
Acute wounds follow the normal healing path and are generally resolved within 8-12 
weeks; however chronic wounds like diabetic foot ulcers, pressure ulcers, venous leg 
ulcers, are difficult to heal and generally exceed 12 weeks to full resolution [4,5].  
1.1. The Wound Healing Process 
Wound healing is a continuous process that follows a complex series of cellular and 
biochemical cascades occurring in orderly, sequential but overlapping phases to 
repair and regenerate the damaged tissue [6]. The healing process occurs in the 
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following four stages (Figure 1): exudative, inflammatory, proliferative and 
regenerative [7]. Various growth factors, cytokines, chemokines and other 
biomolecules are involved in this process [7,8,9] and their role in wound healing are 
summarised in Table 1. The exudative stage, also called coagulation and 
haemostasis, consists of stopping blood loss and preventing excessive bledding. 
Although the act of bleeding is beneficial; washing the damaged tissue and reducing 
microbial invasion, it is controlled by haemostatic reflex vasoconstriction (local and 
systemic) and by the formation of insoluble fibrin plug, to prevent excessive blood 
loss. As blood interacts with exposed collagen and other components of the 
extracellular matrix, activated platelets release clotting factors and aggregate into a 
plug-like matrix, thus controlling blood loss [10]. Once haemostasis has been 
achieved, the inflammatory (or resorptive) stage begins with an increased infiltration 
of phagocytes (neutrophils and macrophages). The presence of neutrophils is time 
restricted to the early stages of healing, whereas macrophages persist through all 
phases from exudative to regenerative [11]. Within 24-36 hours post-injury, 
neutrophils migrate into the wound site and initiate phagocytic activity of 
macrophages by releasing proteolytic enzymes, chromatin, protease ‘traps’ and free-
radical reactive oxygen species (ROS), with concurrent localised inflammation, heat 
and redness. The combined activity of neutrophils and macrophages helps to clear 
damaged and/or necrotic tissues, particulate contaminants and microorganisms from 
the wound site [12,13,14]. To enable the healing process to progress, neutrophils are 
removed from the wound site by apoptosis, phagocytosis (by macrophages), and 
disposal from the surface by sloughing or autolytic debridement. Modified monocyte 
macrophages arrive at the wound site 48-72 hours post-injury and phenotypically 
change into reparative tissue macrophages [11,15,16] that both promote and resolve 
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inflammation as well as removing apoptotic cells (by phagocytosis) [13,14]. 
Macrophages stimulate angiogenesis and granulation tissue formation in the later 
stages [17]. Infected wounds typically become halted in the inflammatory stage and 
hence fail to follow the normal healing process [18]. Wound debridement, which 
involves the removal of non-viable, hyperkeratotic tissue and microorganisms, is a 
vital stage of the healing process; chronic wounds can develop from a combination 
of poor debridement and microbial invasion, that both delay proliferation and tissue 
regeneration [19].  
Once autolytic debridement is successfully achieved and the immune response has 
resolved, wound healing progresses into the proliferation stage which is the phase of 
tissue formation. During this stage tissue repair starts and wound closure is initiated. 
The wound site is filled with granulation tissue and epithelialisation from the wound 
edges takes place. The epithelial cells around the wound edges divide mitotically 
and migrate until a continuous sheet of cells is formed. Collagen (type III) formation 
by fibroblasts acts as a provisional matrix and provides strength to the newly formed 
granulation tissue which is responsible for scar formation [6,20]. To ensure the 
supply of oxygen and nutrients to newly formed tissue, angiogenesis also occurs at 
this stage with a microvascular network of new blood capillaries forming from the 
surrounding viable blood vessels [14,21]. The final stage of wound healing is 
regeneration where normal dermal architecture is restored and scar tissue tensile 
strength increased. Inflammatory cells clear from the regenerated area whilst 
collagen undergoes remodelling to increase the tensile strength of the tissue [6].  
Healthy wound healing follows these sequential stages but delayed healing can 
result from several factors, including, but not limited to, underlying long term disease 
states such as diabetes, an impaired (HIV) or altered immune response (patients 
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undergoing immunosuppression therapy) and/or a high level of microbial burden on 
and around the wound [22,23].    
A retrospective cohort analysis revealed that during 2012/2013, the total annual 
health economic burden spent by the National Health Service (NHS) in the UK on 
wound management was nearly £5.3billion which equated to approximately 4% of 
the annual public health expenditure in the UK in 2013 (£125.5 billion), spent on 
wound management alone. During this year, wound care was provided to estimated 
2.2million patients and the outcome of the treatment revealed that only 61% wounds 
healed whereas 39% of wounds didn’t heal during the duration of the study. Since 
many chronic non-healing wounds do not respond to the standard care, the cost of 
management for these wounds was substantially greater (£3.2 billion) than acute 
wounds (2.1 billion) [24]. While chronic non-healing wounds occur in all age groups 
but these are prevalent in elderly population. Moreover, obese community and 
diabetic patients are more at risk. Globally, the population is aging rapidly; obesity 
and diabetic cases are also increasing, which is leading to the staggering increase of 
number of chronic wound. Studies suggested an estimated annual increase of 6-7% 
in the number of venous and pressure ulcers and around 9% increase in cases of 
diabetic ulcers, which would put extra financial strain on health services [25].   
Despite the emergence of new therapies and vast variety of dressings, there is still 
an urgent need for effective approach to tackle this growing challenge and hydrogels 
are a vital candidate as an advanced wound dressing to encounter this problem.  
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Figure 1. Illustration of the stages of wound healing, (a) Exudative stage with the 
formation of blood clot (b) Inflammatory stage, marked with oedema, pain and 
inflammation (c) Proliferation stage with granulation tissue formation and (d) 
Regenerative stage, characterised by scar tissue formation. 
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Table 1. Important mediators in wound healing process with their respective 
receptors, cell sources, targets and roles in wound healing.
13 
Factor Family Receptors Cells Function Level in acute 
wounds 
Level in chronic 
wounds 
Reference 
PDGF PDGF-BB 
Additional: 
PDGF-AA 
PDGF-AB 
PDGF-CC 
PDGF-DD) 
Tyrosine kinase: 
α-receptor 
β -receptor 
Platelets 
Fibroblasts 
Endothelial cells 
Macrophages 
Keratinocytes 
Chemotaxis 
Proliferation of 
fibroblasts 
Promote blood vessel 
maturation 
Matrix deposition 
Reepithelialisation 
Increased levels Decreased levels 14 
26 
27 
28 
29 
30 
FGF FGF-2 or 
bFGF 
Additional: 
FGF-7 
FGF-10 
KGF 
Total: 23 
members 
Tyrosine kinase: 
FGFR 1-4 
Keratinocytes 
Mast Cells 
Fibroblasts 
Endothelial cells 
Angiogenesis 
Formation of 
granulation tissue 
Reepithelialisation 
Increased levels Decreased levels 14 
26 
31 
32 
33 
34 
EGF EGF 
TGF-α 
HB-EGF 
Additional: 
Amphiregulin 
Epiregulin 
Betacellulin 
Neuregulins 
Tyrosine kinase: 
EGFR 
HER2 
HER3 
HER4 
Platelets 
Macrophages 
Fibroblasts 
Formation of 
granulation tissue 
Reepithelialisation 
Increases tensile 
strength in wound 
Increased levels Decreased levels 14 
26 
31 
32 
35 
36 
37 
VEGF VEGF-A 
Additional: 
VEGF-B 
VEGF-C 
VEGF-D 
VEGF-E 
PLGF 
Tyrosine kinase: 
VEGFR-1 
VEGFR-2 
VEGFR-3 
Platelets 
Endothelial cells 
Macrophages 
Lymphocytes 
Neutrophils 
Keratinocytes 
Vasculogenesis 
Angiogenesis 
Increased levels Decreased levels 14 
26 
28 
30 
32 
35 
38 
39 
TGF-β TGF-β1 
Additional: 
Serine-threonine 
kinases: 
TGFβRI 
Platelets 
Macrophages 
Fibroblasts 
Angiogenesis 
Chemotaxis 
Increased levels Decreased levels 14 
26 
35 
14 
 
TGF-β2 
TGF-β3 
 
TGFβRII 
 
Keratinocytes Reepithelialisation 
 
Anabolism of ECM 
 
Collagen production 
by stimulating 
fibroblasts 
 
Cellular proliferation 
and differentiation  
39 
40 
Proinflammat
ory cytokines 
IL-1 
IL-6 
 
Additional: 
TNF-α 
IL-8 
IL-11 
IL-27 
 
ICAM-1 
IL-6Rα 
 
Monocytes 
Neutrophils 
Macrophages 
Keratinocytes  
 
Chemotaxis 
 
Inflammation (except 
IL-27) 
 
Reepithelialisation 
 
Collagen synthesis 
 
Synthesis and 
breakdown of ECM 
 
Regulation of immune 
response 
Increased levels at 
initial healing stages 
Persistent 
Increased levels 
14 
26 
39  
41 
42 
  
 
Abbreviations: PDGF: Platelet-Derived Growth Factor, FGF: Fibroblast Growth Factor, KGF: Keratinocute growth factor, EGF: 
Epidermal Growth Factor; TGF-α: Transforming growth factor-alpha; HB-EGF: Heparin binding EGF, VEGF: (Vascular Endothelial 
Growth Factor), PLGF: Placenta growth factor, TGF-β: (Transforming Growth Factor- β); IL: (Interleukin); TNF-α: Tumor necrosis 
factor-alpha  
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1.2. Wound Dressings 
Historically, wound dressings were designed to protect the wound site from external 
environment and played a passive role in healing process [43]. The range of 
available passive barrier-type wound dressings, e.g. gauze and tulle, increased as 
medical understanding of the wound healing process improved [44]. Such dressings 
undoubtedly are inexpensive and provide some protection, but being passive, cannot 
respond to changing wound conditions or deliver medicaments in a controlled or 
sustained manner to enhance the healing process. For wounds that follow the 
normal healing process, conventional, barrier-type dressings may be effective; 
conversely, chronic non-healing wounds can easily become infected thereby failing 
to progress through the normal stages of healing. Correct clinical management thus 
becomes imperative to minimise complications during wound healing [1,45]. 
Ideal dressings not only cover and protect the affected area, but can also create 
optimal moist environment at the wound site and facilitate healing [46,47,48,49,50]. 
Advanced wound management strategies involve non-invasive monitoring of healing, 
pain management and the controlled release of agents capable of promoting 
regeneration, repair and scar minimisation [51].  
The concept of moist healing, as proposed by George Winter, revolutionised the field 
of wound management, and the focus of wound dressing changed from conventional 
dry passive products, to responsive moisture-promoting materials [52,53]. Dressing 
types used to achieve a moist wound healing environment include films, 
hydrocolloids, foams and hydrogels (Table 2). 
Table 2. List of commercially available dressings based on the concept of moist 
wound healing environment. 
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Type of 
dressing 
Characteristics Cautions Proprietary products Reference 
Film dressings  Polyurethane films with 
an adhesive to hold the 
dressing  
 Create moist healing 
environment  
 Elastic, durable and 
conformable 
 Waterproof and 
transparent 
 Semi-permeable to 
water vapour and gases 
 Impermeable to 
bacteria 
 Impervious to liquids 
such as wound fluid 
 No secondary dressing 
required 
 
 Being non-
absorbent, limited 
use for highly 
exuding wounds  
 Being adhesive, 
newly formed 
epithelium could be 
disrupted during 
removal 
 Frequently develop 
leakage channels 
Opsite
®
 Films (Smith & 
Nephew) 
Tegaderm
TM
 (3M
TM
, UK 
Plc.) 
Mepitel
®
 Film (Mölnlycke 
Health Care Limited) 
45 
50 
 
Hydrocolloid 
dressings 
 Moist wound dressing  
 Capable of absorbing 
wound exudate 
 Usually made of 
polyurethane film with 
an adhesive mass 
 Adhesive mass is often 
composed of gelatin, 
pectin and sodium CMC 
which swells on 
absorbing exudate 
 Impermeable to water 
and gases  
 
 Not indicated for 
infected or heavy 
exudating wounds 
 Being opaque 
difficult to follow 
the healing process 
without prior 
removal 
 May produce a 
distinct odour at 
wound site 
DuoDERM
®
 (ConvaTec 
Inc,) 
 
 3M
TM
  Tegaderm
TM
 
hydrocolloid dressing 
(3M
TM
, UK Plc.) 
 
Replicare
 ®
  (Smith and 
Nephew) 
 
55 
56 
57 
58 
 
 
 
Foam dressings  Bilaminate (or 
trilaminate) moist 
wound dressing with 
varying thickness 
 Excellent absorption 
capacity 
 Can expand and 
conform to wound 
shape 
 Easy to remove 
 Can be loaded with 
antimicrobials and 
other active agents   
 Not suitable for low 
exudating wounds 
 Frequent change 
may be required for 
heavy exudating 
wounds 
 May cause 
maceration on 
saturation with 
exudate  
Mepilex
 ®
  and  Mepilex 
Ag
 ®
 (Molnlycke Health 
Care) 
 
Allevyn (Smith and 
Nephew) 
  
Aquacel
®
 (ConvaTec Inc.) 
 
Cutimed
®
 Siltec B (BSN 
medical Inc.) 
 
Biatain
®
 Silicone Ag 
(Coloplast Ltd.) 
 
59 
60 
61 
 
 
 
Hydrogel 
dressings 
 Insoluble aqueous gels 
as moist wound 
dressing  
 Moisture retention 
and donation 
properties 
 Usually non-adhesive 
 Some hydrogels 
are mechanical 
weak in swollen 
state but 
mechanical 
properties can be 
enhanced by 
Purilon
®
 Gel (Coloplast 
Ltd) 
 
Derma-Gel (Medline Ind. 
Inc.)
 
 
Intrasite
®
 Gel (smith & 
3 
61 
62 
63 
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so easy to remove 
 Can be loaded with 
antimicrobials and 
several active wound 
healing agents   
 Can be smart and 
stimuli responsive 
 Can be injected 
 Can be crosslinked In 
situ  
copolymerisation 
with appropriate 
polymer(s). 
 May cause 
maceration  after 
accumulation of 
exudate 
 May require 
secondary dressing  
 
 
Nephew) 
 
In addition to the above examples of commercially available dressings, there is a 
plethora of wound dressing products available on the market today, aiming at 
promoting wound healing, including Adaptic Touch® (a non-adhesive silicone 
dressing by Systagenix Wound Management Limited), ALGICELL® and Algosteril® 
(an alginate dressing by Derma Sciences Inc. and calcium alginate dressing by 
Smith & Nephew, UK respectively), AltrazealTM (by ULURU Inc., a white wound filler 
powder dressing that transforms into a malleable protective dressing on contact with 
the exudate that  fills the wound,), BIOSTEPTM (by Smith & Nephew, UK, a collagen 
matrix dressing that optimises wound closure by deactivating excess matrix 
matalloproteinases) and Drawtex® (hydroconductive dressing by Beier Drawtex 
Healthcare, featuring LevaFiberTM technology works by capillary, hydroconductive 
and electrostatic action).  
In addition to these dressings, hydrogel dressings are one of the most versatile 
advanced form of moist wound dressings [64] that are commercially available in 
different forms. AmeriGel® (Amerx Health Care Corp., a hydrogel dressing with 
moisture sustaining properties), ActiGuardTM (by Dynarex Inc., a hydrogel sheet 
dressing that is permeable to air and water vapours enhancing wound breathe) and 
Intrasite® gel (smith&nephew Inc., an amorphous hydrogel dressing that helps in 
optimising wound environment for re-epithelialisation), are some of the proprietary 
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hydrogel dressings. The current review would give readers a comprehensive 
overview of hydrogels as wound dressings. Moreover, the routine scientific 
approaches of preparing hydrogels for wound management applications, forms of 
commercially available hydrogel wound products, and the material aspect of 
hydrogel production with their laboratory characterisation tests are discussed using 
up-to-date literature.     
1.3. Hydrogel Dressings  
Hydrogels are composed of water insoluble, cross-linked polymers with a high 
affinity for aqueous media. These three dimensional polymeric gels have a 
hydrophilic, porous structure that permits a massive degree of water absorption, 
several times greater than the original dry weight [3,65,66]. The hydrophilic 
properties of hydrogels are related to the cross-linking density of polar functional 
groups such as amide, amino, carboxyl and hydroxyl in the polymer structure 
[67,68,69,70,71]. Hydrogels offer the unique properties of high water content (up to 
99.5%), non-adhesive nature, malleability and a resemblance to living tissues in 
terms of their biocompatibility [43,63,65,72,73]; all combine to make them an ideal 
dressing candidate. Moreover, hydrogels display the property of swelling and de-
swelling reversibly in aqueous solutions, hence their application in a range of sectors 
including regenerative medicine, drug delivery and the focus of this review, wound 
management.  
Hydrogels help promote wound healing [74] via their moisture exchanging activities 
that develops an optimum microclimate between the wound bed and the dressing 
[67, 75]. Due to their high moisture content, these dressings also provide a cooling, 
soothing effect; reduce the pain associated with dressing changes [76]. In addition, 
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the limited adhesion of hydrogels means that they can be easily removed from the 
wound, without causing further trauma to the healing tissue [77]. The transparent 
nature of some hydrogel dressings also allows clinical assessment of the healing 
process, without the need to remove the dressing.  
Hydrogels can be formulated to behave in a stimuli responsive manner [74] so that 
when loaded with a drug or active biomolecule they are able to control diffusion and 
release, thus making them truly interactive dressings [78,79]. Moreover, hydrogel 
have been successfully used as a matrix for the fabrication of dressings for the 
sustained delivery of essential growth factors (Table 1) and healing agents to 
facilitate wound healing [28,29,31] (Figure 2). All these properties resulted into 
several proprietary hydrogel wound dressings used in clinical practice for wound 
management all over the globe. Due to their unique properties, hydrogel dressings 
are indicated for use in variety of wounds such as, but not limited to, dry wounds with 
necrotic tissue, burn wounds, diabetic foot ulcers, pressure ulcers, chronic leg ulcers 
and low to moderately exudating wounds [56,80,81,82]. In spite of the various 
hydrogel dressing products already in the market, there is still an ongoing research 
in the area with the aim to further improve the hydrogel dressings covering patient 
comfort, clinical efficacy and multiple aspects of wound healing.  
Figure 2. Schematic illustration of (a) Drug loaded homo-polymeric pH responsive 
hydrogel (b) Hetero-polymeric bioactive material loaded temperature responsive 
hydrogel (c) Growth factor loaded homo-polymeric hydrogel, with their release 
trends. 
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2. Preparation of Hydrogels  
Hydrogels can be prepared from various natural and synthetic polymers, using a 
range of different compositions as well as physical and chemical cross-linking 
techniques. The crosslinks in hydrogels can be due to covalent bonds, ionic 
interactions, chain entanglements, etc., leading to a variety of physical 
configurations, chemical arrangements and interactions. Interestingly, it is the very 
nature of the cross-linkage that determines much of the hydrogel’s physicochemical 
properties and hence eventual applications. 
2.1. Physically crosslinked hydrogels are formed by the physical linking of 
polymer chains via molecular entanglement, ionic interactions, hydrogen bonding or 
hydrophobic association [83]. Several thermodynamic changes e.g. heating or 
cooling of polymer solutions, freeze-thawing, lowering pH, selection of anionic and 
cationic polymers can result in physical crosslinking between polymeric chains [69, 
84,85,86]. Preparation of these hydrogels involves relatively mild conditions and 
simple purification procedures as no toxic chemical crosslinking agents are required 
during their synthesis; offering them exceptional biological nontoxic, biocompatible 
properties thus making them ideal matrix for the delivery of therapeutic agents at 
wound site [66,87]. 
2.1.1. Ionic interactions: These hydrogels are formed between ionic polymers 
crosslinked with multivalent, counter charged species. Polyanionic polymers that are 
complexed with polycationic polymers form hydrogels by a process of polyelectroyte 
complexation, which is also referred to as complex coacervation [88]. Alginate 
hydrogel dressings using divalent calcium cations (CaCl2) are commonly synthesised 
by this technique [89,90].  
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2.1.2. Crystallisation: Hydrogels for wound management applications can also be 
synthesised by freeze-thawing. During freeze-thawing of an aqueous polymeric 
solution, water freezes causing phase separation which leads to the formation of 
microcrystals [91,92]. Repeated freeze-thaw cycles facilitate reinforcing existing 
crystals within the structure and offers higher crystallinity and added stability upon 
swelling [87,93].  Physically crosslinked biocompatible and elastic hydrogels using 
PVA/PEG polymers [92] and PVA/sodium alginate [94], fabricated by consecutive 
freeze-thaw cycles as a potential wound dressing formulation are examples of this 
type of gelation.  
2.1.3. Hydrogen bonding between chains: This class of hydrogels can be 
produced by lowering the pH of aqueous polymer solutions, when carboxylic groups 
are present on the chains. At acidic pH aqueous polymer solubility is reduced which 
promotes hydrogen bonding and the formation of hydrogels [95]. However, these 
physical networks can easily disperse with the influx of water therefore in addition to 
these other type of crosslinking can be considered to hold the hydrogel constituents 
[96]. Hydrogels with pH sensitive gelation (around pH 6.5) of chitosan can be 
produced by these physical interactions [97]. 
 2.1.4. Amphiphilic block copolymers: These physical hydrogels are made from 
two chemically different homopolymer blocks one of which is hydrophobic and the 
other is hydrophilic. These copolymers self-assemble in aqueous media forming 
hydrogels due to thermodynamic incompatibility between the blocks [98,99].  
Moreover, drugs like antimicrobials can be incorporated in these copolymers and 
sustained release can be achieved for wound management applications [100,101]. 
Thermoresponsive poly(Ɛ-caprolactone)-poly(ethylene glycol) block copolymer 
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hydrogels with potential wound dressing applications are a good example of this 
category [101,102,103].  
2.1.5. Protein interactions: With the advancement in biotechnology, hydrogel 
synthesis by engineering of recombinant proteins has become possible.  This new 
development in the field of material chemistry pioneered by Tirrell and Cappello 
[104,105] allows to control the structural and functional design of protein block thus 
preparing the physically crosslinked hydrogels with desirable biological, physical and 
mechanical properties. These biopolymeric protein based hydrogels primarily 
assemble by protein-protein interactions or aggregation of polypeptides by phase 
(temperature) transitions [106]. It can be foreseen that these hydrogels hold a strong 
potential in wound management. Fabrication of protein engineered bioactive 
collagen-mimetic protein (eColGFPGER) with PEG based matrix hydrogel dressings 
with a potential of wound healing in humans is an innovative approach in  the field of 
wound management [107].    
2.2. Chemical crosslinked hydrogels are formed by covalent linkages resulting in 
high mechanical strength networks. These can be synthesised by chain growth 
polymerisation, addition and condensation polymerisation and high energy 
irradiations (gamma ray or electron beam).  
2.2.1. Crosslinking by chain growth polymerisation: It includes three stages: 
initiation, propagation and termination.  Generation of free radical site by suitable 
reaction initiator initiates the polymerisation process followed by chain elongation by 
the addition of low molecular weight monomeric building blocks. The elongated 
polymer chains are randomly crosslinked by the cross-linking agent leading to the 
hydrogel formation [108]. Hydrogel of 2-acrylamido-2-methylpropane sulfonic acid 
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sodium salt (AMPS-Na+) using potassium persulfate as a free radical initiator and 
ethylene glycol dimethacrylate as a crosslinking agent can be synthesised by redox 
initiation via free radical polymerisation for wound dressing applications [109]. 
Chemically crosslinked hydrogel of AMPS with AMPS-Na+ prepared by using 4,4-
azo-bis(4-cyanopentanoic acid) as photo-initiator and N,N’-methylene-bisacrylamide 
as a cross-linking agent demonstrated optimum water absorption and retention 
properties for wound management applications. Moreover, their flexible and 
transparent nature with good skin adhesion properties advocates their potential 
biomedical applications [110].  
2.2.2. Crosslinking by chemical reactions of complementary groups: 
Hydrophilic polymers have functional groups like COOH, OH and NH2 which can be 
utilised for the hydrogel formation. These pendant functional groups with 
complementary reactivity (amine-carboxylic acid or isocyanate-OH/NH2 reaction or 
Schiff base formation) can establish covalent linkages between polymer chains 
leading to the hydrogel formation using crosslinking agents [111,112,113]. 
Antibacterial alginate-chitosan hydrogel wound dressings can be synthesised by the 
Schiff based reaction between aldehyde group of oxidized alginate and amino group 
of carboxymethyl chitosan [111]. Injectable in situ chitosan-hyaluronic acid hydrogels 
[114] for wound applications are another example with gelation attributing to Schiff 
base between amino group of carboxymethyl chitosan and aldehyde group of 
aldehydic hyaluronic acid. Being injectable, these hydrogel dressings hold an added 
advantage of easy and comfortable application with high conformability without 
wrinkles which could lead to improved patient compliance.    
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2.2.3. Crosslinking by using high energy radiations: Cross-linking by radiations 
is widely used to polymerise unsaturated compounds for hydrogel synthesis since it 
is devoid of the use of toxic chemical crosslinking agents and is a cost effective 
technique as separate sterilisation of hydrogel formulation can be avoided. On 
exposure to high energy radiations, radicals are formed on polymer chains in an 
aqueous solution which initiates free radical polymerisation. Recombination of these 
radicals on different polymer chains lead to the formation of covalent crosslinked 
hydrogels [66,88].  Silver nanoparticles loaded AMPS-Na+ hydrogels [115], PVA/gum 
acacia [116] and nanosilver/gelatin/carboxymethyl chitosan hydrogels synthesised 
by gamma (cobalt-60) irradiation technique are examples of potential antimicrobial 
hydrogel wound dressings [117]. 
  
3. Hydrogel dressing products: 
There are many different types of wounds with multitude of different symptoms, 
including necrotic, sloughy, granulating and epithelialising that vary in size, shape 
and thickness. Understanding the purpose and principle of dressing formulations for 
these differing applications helps to match the correct dressing and wound 
combination.  
Hydrogel dressings are indicated for the treatment of a variety of wound types, with 
precise selection of formulation ultimately based on clinical application: 
a. Amorphous hydrogels: Lacking a fixed shape, these hydrogels can be evenly 
applied over the wound using an applicator and being amorphous, these would 
mould into the shape of wound defect easily. These are specifically indicated in 
the treatment of uneven or cavity wounds that cannot be easily covered with fixed, 
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definite shape dressings. Examples of commercially available products include: 1) 
Aquasite®, an amorphous, glycerine-based hydrogel dressing [Derma Sciences 
Inc.], and 2) Intrasite® gel, a partially hydrated, amorphous propylene glycol 
hydrogel [Smith & Nephew, UK]. 
b. Impregnated hydrogel gauze dressings: Used for partial or full thickness 
wounds where sterile packing of the wound bed is required, these formulations 
combine the advantages of hydrogels with non-woven dressings. Impregnated gauze 
dressings are saturated and/or permeated with an amorphous hydrogel and are 
commercially available as gauze pads, non-woven sponges and strips of different 
sizes. Commercially available products under this category are: 1) Aquasite® 
impregnated gauze dressing, a 100% cotton gauze pads incorporated with a 
hydrogel [Derma Sciences Inc.], and 2) Intrasite® conformable, hydrogel 
impregnated gauze dressings [Smith & Nephew, UK]. These dressings are available 
in various sizes and are indicated for use in necrotic, sloughy and granulating full 
thickness wounds.  
c. Sheet hydrogel dressings: Consisting purely of hydrogel, these dressings can 
be cut into the required size and shape to fit the wound. Hydrogel sheet dressings 
are indicated for the treatment of deep cavity and partial thickness wounds (e.g. 
ulcers, including venous and arterial, pressure sores, skin donor sites, surgical 
incisions, 1st and 2nd degree burns). Aquasite® hydrogel sheet dressing, glycerine 
based hydrogel formulations [Derma Science Inc.] and Flexigel® sheet, 
polyacrylamide based hydrogel sheet dressings [Smith & Nephew, UK] are 
commercially products available in different sizes (e.g. 2”x2” and 4”x4”) and can 
be easily cut to fit wound. These act as advanced wound dressing by keeping the 
wound bed moist thus offering soothing effect and facilitate wound healing as well 
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as providing physical barrier between wound and external environment. Moreover, 
being transparent, these sheet dressings allow easy monitoring of healing 
process. 
4. Polymers suitable for hydrogel wound dressings:  
Some polymers due to their physicochemical and biocompatible properties are 
extensively used in biomedical applications. Most commonly used polymers used for 
fabricating hydrogel for wound dressing applications are discussed below. Moreover, 
other commonly used polymers with wound dressing applications are listed in Table 
3.  
4.1. Poly(vinvyl alcohol) (PVA) 
PVA being biocompatible, transparent and capable of maintaining moist environment 
has attracted application in wound care [118,119]. PVA chains can be crosslinked to 
produce PVA hydrogels by variety of techniques including freeze-thawing cycle, 
electron beam irradiation and using cross linkers like glutaraldehyde [53]. Hwang et 
al., (2010) [120] employed a freeze-thaw technique to produce a gentamicin-loaded 
PVA-dextran hydrogel dressing. The authors suggested that the presence of dextran 
in the hydrogels enhanced the elasticity, swelling ability and water vapour 
transmission rate (WVTR) of hydrogel. Moreover, dextran favours the crystallisation 
of PVA, thus producing a more uniform, homogenous gel structure.  In vitro test 
results confirmed the hydrogel formulated with 2.5% PVA, 1.13% dextran and 0.1% 
gentamicin was haemocompatible thus suitable for wound management applications. 
Moreover, in vivo (rat model) tests revealed enhanced healing with greater wound 
size reduction of a full thickness surgical excision wound of the dorsum with 
gentamicin-loaded-PVA-dextran hydrogels compared to the foam dressing 
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(MedifoamTM) and gauge dressing. The re-epithelialisation rate of gentamicin loaded 
resulting hydrogel was significantly higher (98±2%) than conventional foam dressing 
(74±14%) which supporting its potential wound dressing application.  
 
Sodium ampicillin containing PVA-Sodium Alginate (PVA-SA) hydrogel membranes 
for wound dressing applications were synthesised by Kamoun et al., (2015) [94]. The 
authors achieved physical crosslinking (entanglement) between PVA and different 
content of SA by repeated freezing-thawing cycles. In vitro protein adsorption test 
was performed to determine the ability of the hydrogels with regards to cleansing the 
secreting lesions and the results suggested an increase in bovine serum albumin 
(BSA) adsorption from 0.7-1.8mg/cm2 with an increase in SA content from 0-75% 
(w/w). These membranes demonstrated high haemocompatibility and broad 
antibacterial activity suggesting their potential application as an active biodegradable 
hydrogel dressing in wound care. In another study, PVA based hydrogel dressing 
was developed in situ by co-enzymatic reaction using glucose present in wound 
exudate to trigger crosslinking. Glucose oxidase (GOx) and horseradish peroxidase 
(HRP) were used to catalyse the hydrogelation process. GOx oxidised glucose to 
H2O2 which in the presence of HRP was taken by phenolic hydroxyls of the PVA 
derivative (PVA-Ph) leading to the hydrogel formation. The authors presented in vivo 
findings suggesting significantly faster cure of full-thickness wounds (rat model) with 
77% and 96% wound closure at 7 and 10 days of treatment, respectively compared 
to only 27% at day 7 and 70% at day 10, with commercially available hydrogel 
dressing [121].    
4.2. Poly(N-vinyl-2-pyrrolidone) (PVP):  
29 
 
PVP, a well-known synthetic polymer due to its biocompatible nature has attracted 
several biomedical applications including wound management. Nu-Gel® (Systagenix) 
and  Neoheal® (Kikgel) are PVP based proprietary hydrogel products indicated for 
use in first and second degree burns, severe sun burns, partial thickness wounds, 
ulcerations and bedsore. PVP undergoes crosslinking under ionising radiation, 
resulting in transparent hydrogels but these hydrogels have poor mechanical 
properties with limited swelling. It’s swelling behaviour and mechanical properties 
can be enhanced by blending it with other polymers such as polysaccharides 
[122,123,124,125,126]. The use of ionizing radiations is considered to be a 
favourable tool, wherever feasible, for hydrogel formation (and sterilisation) due to 
easy process control, minimal wastage, low cost and no chemical crosslinkers 
requirement [123,127].  
Fechine et al., 2004 [128] reported an approach to synthesis PVP hydrogel using 
safer, portable and less expensive UV radiation (λmax 254nm) technique. They 
produced hydroxyl radicals from the photolysis of H2O2 and these radicals were 
reacted with PVP giving rise to macroradical polymer chains which underwent 
recombination leading to the hydrogel formation. The hydrogel produced 
demonstrated in vivo cytocompatibility with satisfactory low inflammation index in 
rabbit model (72hr direct contact with rabbit skin) hence classified as non-irritating 
material for wound management purposes.  
Jovanovic et al., (2011) [129] reported an approach to synthesise antimicrobial PVP 
hydrogels using gamma radiation to achieve gelation. Antimicrobial properties in 
these hydrogels are attributed to silver nanoparticles produced in situ in PVP 
hydrogel matrix by reduction of silver nitrate with radiolytic products of water up on 
gamma irradiation. These nanocomposite hydrogels exhibited high elasticity, good 
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mechanical properties and good swelling capacity and may be tailored for potential 
wound dressing applications.    
Another attempt of fabricating antimicrobial silver nanoparticles (AgNP) loaded PVP 
based blend hydrogel using gamma radiations was made by Khampieng et al., 2018 
[130] for wound management of chronic wounds. The blend of PVP with alginate and 
chitosan in the ratio of 10:1.2:1.8 respectively enhanced the swelling and mechanical 
properties making these hydrogels suitable for dressing applications. When 
compared to three commercially available dressings (ActicoatTM, Algivon® and 
Suprasorb® A + Ag), these hydrogels (10mM AgNP concentration) showed superior 
cytocompatibility with higher cell viability against mouse (112.64±4.66%) fibroblasts 
(L929), human dermal fibroblast (89.47±1.11%) and human keratinocytes (HaCaT) 
cells (105.35±4.52%). Moreover, the maximum swelling behaviour (2267±109%) of 
these resulting hydrogels was superior to ActicoatTM (362±66%). These findings 
suggested their greater capability of absorbing wound exudate thus making them a 
potential candidate for chronic wounds including pressure ulcers.     
4.3. Poly(ethylene glycol) (PEG):  
PEG is a polyether which attracted a wide interest in the biomedical applications 
including wound management due to its transparent, non-toxic, non-immunogenic, 
biocompatible and biodegradable properties [131, 132]. PEG fumarate [133] and 
PEG acrylates like PEG diacrylate (PEGDA) [134,135], PEG dimethyacrylate 
(PEGDMA) [136] and PEG methyl ether methacrylate (PEGMEMA) are some of the 
commonly used acrylates in hydrogel formation for biomedical applications.  Due to 
its featured biological properties, PEG has been used in proprietary products like 
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AquafloTM (Covidien), Neoheal® (Kikgel) and AmeriGel® (Amerx Health Care Corp.) 
hydrogel wound dressings.  
Since chronic wounds are associated with alkaline pH, with an aim to restore the 
elevated pH to the physiological pH (7.4), in order to facilitate healing, Koehler et al., 
2017 [131] fabricated a pH-modulating acidic PEGDA/Alginate hydrogel dressings 
containing acrylic acid (AA). In addition to controlling the alkaline pH neutralisation, 
AA enhanced the swelling capacity of the hydrogels. PEGDA/AA/alginate hydrogels 
with 0.25%AA demonstrated superior mechanical strength, biocompatibility and 
enhanced cell migration velocity (19.8 ± 1.9µm h-1) in a 2D cell migration assay 
leading to a complete wound closure. Also, the ingrowth of keratinocytes increased 
by 164% (3D Human skin constructs and Healing assay) compared to untreated 
control. Chen et al., 2013 [48] prepared a PEG/chitosan hydrogel dressing by using 
PEG diacid (PEG with carboxylic acid groups at both ends) crosslinked to chitosan 
by way of ester and amide linkages.  Authors reported that PEG/chitosan with the 
mole ratio of carboxylic acid from PEG diacid (PEG molecular weight 1000Da) to 
amine group from chitosan of 90/10 offered good mechanical properties and 
appropriate degradation rate. Also, in vivo wound treatment studies (mice model) 
revealed the capability of these hydrogels to suppress inflammation, with fewer 
inflammatory cells, enhance re-epithelialisation and increased angiogenesis thus 
supporting their potential use as a biomaterial for wound dressings.  
In another study, Dong et al., 2014 [137] formulated a wound dressing hydrogel 
using PEG-based multifunctional hyperbranched copolymer crosslinked with 
thiolated hyaluronic acid (HA-SH) with adipose-derived stem cells (ADSC). These 
polymers stay as a solution at room temperature while they undergo in situ 
crosslinking (thiol-vinyl Michael addition between vinyl groups on copolymer and thiol 
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on HA-SH) at body temperature, forming a stable, non-adhesive and bioactive 
hydrogel (within 8 minutes) at the wound site. Being injectable, these can be easily 
and effectively applied to any wound shape and size. Although in vivo studies (rat 
model) revealed that these hydrogels resisted wound contraction to some extent but 
there was a strong evidence of their angiogenesis enhancing ability.  
4.4. Poly(2-hydroxyethyl methacrylate) (PHEMA): PHEMA was the first 
hydrogel used  in the production of soft contact lenses due to its inert nature, 
biocompatibility, excellent mechanical strength and high water imbibing properties 
[138]. In addition to its biomedical application as a contact lens material, due to its 
exceptional physicochemical properties and accepted in vivo tolerance, it has 
attracted its use in wound management as a hydrogel dressing material [139].  
Halpenny et al., 2009 [140] reported the use of PHEMA in the fabrication of the 
bactericidal light sensitive hydrogel wound dressing. With inherent would healing 
properties and to avoid potential emergence of antibiotic resistance, nitric oxide (NO) 
was selected as an antimicrobial agent. In order to deliver NO to a desirable site with 
controlled release, authors developed photoactive NO donors (nitrosyls) which were 
incorporated into polyurethane that was covalently incorporated into pHEMA 
hydrogel.  In order to enhance the antimicrobial activity of these hydrogels, H2O2 or 
methylene blue were used as auxiliary growth attenuators.  When these hydrogels 
were tested against P. aeruginosa and E. coli, significant antimicrobial activity was 
recorded. Authors proposed that this approach was superior to washing the wound 
site with 3% H2O2 solution. This study demonstrates the futuristic approach of 
fabricating hydrogels with an added advantage of controlled release of antimicrobial 
by illuminating (stimuli) the dressing (exposure to light) from time to time to maintain 
antiseptic conditions at the wound site.  
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Singh and Dhiman, 2015 [75] produced antibiotic (moxifloxacin) containing PHEMA-
based copolymeric hydrogel dressings using carbopol and gum acacia by free 
radical polymerisation method, with potential wound dressing applications. The 
permeability test results showed that these are permeable to oxygen and 
impermeabile to microbes present in open environment. Moreover, their high fluid 
uptake (7.22±0.26g per gram of gel) and retaining property makes these hydrogel 
dressings suitable for application in moderate to high exudative wound with 
potentially 3-5ml exudate per 10cm2 per day. These hydrogels have been proposed 
to be haemocompatible (0.95% haemolytic effect) thus validating their wound 
management applications. Their low albumin absorption (0.19±0.02mg cm-2) which 
could be attributed to highly hydrophilic nature of gum acacia, also favours its wound 
dressing application. Formulations with antioxidant activity may help to reduce 
oxidative stress at the chronic wound site thus promote healing. The results from the 
antioxidant activity [Folin–Ciocalteu (F–C) reagent assay] and superoxide radicals 
scavenging ability (64.21±2.70%) were found promising. In vivo test (mouse model) 
results revealed that unlike gauge dressings, the resulting hydrogels could be 
removed easily removed from wound site without causing trauma. Moreover, wounds 
treated with these hydrogels revealed enhanced healing with well organised 
fibroblasts and angiogenesis compared to open untreated wounds. All these 
properties advocate their wound management applications as wound dressings.  
Controlling the microbial bioburden is a major challenge in chronic wound healing 
and the introduction of antimicrobial agents in the polymeric materials with potential 
biomedical applications is a common practice to tackle this challenge.  Amongst 
different antimicrobial agents, silver is widely used due to its strong antimicrobial 
activity [3]. Several methods have been reported in literature to produce silver 
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nanoparticles [141,142,143,144]. Siddiqui et al., 2016 [145] made a successful 
attempt to produce antimicrobial nanocomposite PHEMA hydrogels with silver 
nanoparticle (AgNPs) using in situ radical polymerisation. These hydrogels exhibited 
good thermomechanical properties with potential wound management applications. 
In another study, with the aim of controlling bacterial bioburden at the wound site 
whilst maintaining the moist environment, Di et al., 2017 [146] synthesised 
transparent antimicrobial PHEMA based hydrogels coated with AgNPs reduced by 
sodium hydrogen borate. Authors added bacterial cellulose to PHEMA to improve its 
flexibility and hydrophilic properties. These hydrogels were tested against two 
opportunistic microbial strains, Escherichia coli (E. coli) and Staphylococcus aureus 
(S. aureus). Disc diffusion results revealed antimicrobial activity with clear zone of 
inhibitions (ZOI) measuring 0.25±0.15cm and 0.50 ±0.15cm respectively for the 
tested strains. Moreover, these finding were confirmed with colony forming unit 
(CFU) method with 99% and 90% reduction in CFU count against the respective 
tested strains, after 24h. Furthermore, these hydrogels exhibited rapid water 
absorption which would minimise the detrimental effect of exudate on wound site. 
Being transparent, these hydrogels would allow monitoring of the healing process 
without the need of removing the dressing. All these properties, along with low 
toxicity results advocate its potential application in wound management.  
4.5. Poly(n-isopropylacrylamide) (PNIPAM): PNIPAM is a smart polymer with 
amide and propyl moieties in its monomeric structure responsible for its temperature 
dependent volume phase transition (VPT at 34ºC). Its lower critical solution 
temperature (LCST) is slightly lower (32ºC) than VPT temperature. Being nontoxic, 
biocompatible and with phase transition close to the human body, it has attracted 
wide biomedical applications [147,148,149].  
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Jiang et al., 2012 [150] synthesised thermoresponsive antimicrobial PNIPAM wound 
dressing hydrogels crosslinked using PEGDA by free radical polymerisation using 
ammonium persulfate (APS) and N,N,N’,N’-tetramethylethylenediamine (TEMED) as 
initiators. Cell interaction properties of PNIPAM were enhanced by using acryoyl-
lysine (A-Lys), which is known to improve cell adhesion and proliferation. 
Polyhexamethylene biguanide (PHMB) with low cellular toxicity and broad spectrum 
activity was used as an antimicrobial agent. In vivo wound healing studies (rat 
model) in normal and infected (with Pseudomonas aeruginosa) wounds 
demonstrated enhanced healing with accelerated wound closure on day 4, with 
21.66±7.94% wound size reduction in PHMB–loaded hydrogels compared to 
untreated control (5.92±4.11%). Furthermore, decrease in surface bacterial 
concentration with PHMB-loaded-PNIPAM hydrogels was also observed as 
compared to untreated control group.  
The bone marrow mesenchymal stem cells (BMSCs) are known to secrete growth 
factors like TGF-β and FGF and accelerate wound healing in healthy skin however 
due to increased protease secretion by high levels of cytokines in inflammatory 
environment of chronic wounds, their activity can be compromised. In order to fully 
harvest the benefit of delivered BMSCs at the wound site, chronic inflammation 
needs to be controlled which would ultimately lead to protease inhibiting activity 
[151,152].  Chen et al., 2015 [151] designed thermosensitive biocompatible PNIPAM 
hydrogel dressings using poly(amidoamine) as a biodegradable cross-linker, to 
deliver the encapsulated BMSCs to the diabetic ulcers. In vivo (diabetic mice model) 
immuno-histochemical studies using CD86 to mark M1 macrophages and CD163 for 
M2 macrophages on day 5 and 7, revealed that the hydrogel treatment inhibited 
chronic inflammation at the wound site as compared to untreated control group. 
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Moreover, the hydrogel enhanced the secretion of growth factors (TGF-β and FGF) 
by BMSCs resulting in the formation of granulation tissue, angiogenesis, ECM 
secretion and re-epithelialisation, leading to healing of wounds in diabetic mice 
model. These finding provide guidance and evidence of efficiency of these hydrogels 
in treating diabetic ulcers.   
4.6. Alginate:  
Alginate, a natural polysaccharide derived from marine brown algae and some soil 
bacteria has attracted wide biomedical application including wound management due 
to its hydrophilic, biocompatible and non-toxic nature [89,153,154,155,156]. Its 
exceptional wound healing properties resulted in its use for fabricating commercially 
available hydrogel dressings like Purilon® Gel (Coloplast Ltd.) and Nu-GelTM 
Hydrogel with Alginate (Systagenix Wound Management Ltd.). Alginate has an ability 
to form hydrogels by addition of divalent cations like Ca2+ which binds to guluronate 
blocks of alginate chains enabling ionic cross-linking between guluronate block of 
adjacent alginate chains in the so called egg-box cross-linking model leading to gel 
formation [157,158,159]. In case of loss of the divalent cationic cross-linker, the 
alginate dressing can easily degrade but this issue is commonly overcome by cross-
linking (ionic or covalent) alginate with other polymers like PVA, gelatine, chitosan 
etc. [43]. Balakrishnan et al., 2005 [160] made an attempt to synthesise a hydrogel 
wound dressings (in situ) by periodate oxidation of sodium alginate (SA) resulting in 
alginate dialdehyde (ADA) and subsequently reacting it with gelatine (G) using 
borax. Ɛ-amino groups of lysine or hydroxylysine groups of gelatine complexed with 
available aldehyde, facilitated by borax, resulting in a crosslinked hydrogel. In 
addition to accelerating this Schiff’s base formation, borax acted as an antiseptic. 
This hydrogel formulation demonstrated optimum WVTR (2686 ± 124 g/m2/day) and 
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water absorptivity. Moreover, the rate of re-epithelialization, in vivo (rat model), was 
significantly enhanced (90.38±9%) in wound treated with hydrogel dressings 
compared to gauge dressings (81.65±9%). Furthermore, wound size was 
significantly reduction in wounds treated with these dressings (95.3±5%) compared 
to gauge dressings (75.5±5%), suggesting their potential application in wound 
management.    
In another study, Saarai et al., 2012 [161] selected SA and G polymers with the 
same objective of obtaining a moist, elastic and biocompatible hydrogel wound 
dressing.  They used various SA and G concentrations to underpin the correct blend 
ratio of SA and G to produce hydrogel with optimum physicochemical properties for 
wound management applications. Based on the results findings, the authors 
proposed SA/G 50/50 ratio to be optimum producing a hydrogel with desirable 
viscoelastic and absorption properties for wound management application.  
4.7. Chitosan: 
Chitosan is a linear natural polysaccharide derived by alkaline N-deacetylation of 
chitin, obtained from exoskeleton of crustacean like crab, lobster and shrimp [162, 
163, 164].  Due to its biocompatibility, haemocompatibility, biodegradable nature and 
featured haemostatic, antimicrobial (bacteriostatic and fungistatic) and wound 
healing properties [48,165,166,167], it is considered fit as wound dressing material. 
Chitosan can be used to produce membrane, sponge, scaffold and it also has 
hydrogel forming ability. However, a hydrogel formulation would be the most suitable 
form as it is able to protect, interact, contract the wound and facilitate wound healing 
by developing optimum moist healing environment [168]. Chitosan can get deformed 
easily through external stress but this challenge can be overcome by blending it with 
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suitable polymers to enhance its mechanical properties for fabricating wound 
dressing [48].  
Ribeiro et al., 2009 [167] developed an antimicrobial chitosan hydrogel dressing 
using lactic acid to induce stoichiometric protonation of the –NH2 sites of chitosan 
followed by exposure to ammonia fumes (later removed). The hydrogel formation 
mainly involved hydrogen bonding and physical entanglement of polymer chains. 
The hydrogel produced was claimed to be porous, favouring gaseous (O2 and CO2) 
exchange and preventing build-up of exudate. In vitro and in vivo experiments 
confirmed the cytocompatibility and histocompatibility (local and systemic) of the 
biomaterial. MTT assay results using fibroblasts cells from rat skin seeded with the 
resulting hydrogel for 24h confirmed cytocompatible nature of this biomaterial. The 
application of these hydrogels in dermal burn wounds was evaluated by inducing full-
thickness transcutaneous dermal wounds in rats. In vivo histological studies further 
confimed the biocompatibility of these hydrogels as no inflammation or specific 
pathological abnormalities were observed during the test period. Macroscopic 
analysis results of wounds treated with these hydrogels revealed considerably 
smaller wound bed compared to control (PBS treated). Clinical application potential 
of these hydrogels for wound management needs to be further evaluated by 
undertaking advanced studies.   
In another study, Wang et al., 2012 [168] reported the development of chitosan, 
honey and gelatine hydrogel sheets for burn wounds. The authors produced sheets 
by varying content of chitosan (not more than 0.5 wt%) and honey (not more than 20 
wt%) but keeping the amount of gelatin constant (20 wt%) and studied the 
physicochemical and functional characterisation of these hydrogel sheets on  burn 
wounds. Chitosan and honey showed a positive synergistic effect as antibacterials in 
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these dressings. Hydrogel formulation with chitosan (0.5 wt%), honey (20 wt%) and 
gelatin (20 wt%) was reported to be the optimal dressing due to its soft moist nature 
and excellent in vitro antimicrobial  activity (100% inhibition rate) against E. coli and 
S. aureus. Biocompatibility of the resulting hydrogels was established by in vivo, 
acute oral toxicity study (mouse model) and dermal irritation test (rabbit model) with 
no noticeable toxic symptoms or skin irritation during set time points of upto 48h. 
Wound healing study (rabbit model) revealed that throughout the study at each set 
time point (on day 4, 8 and 12) hydrogel formulations demonstrated higher wound 
contraction compared to commercially available MEBO® ointment and untreated 
control. The complete recovery of the burn wound was achieved in around 12 days  
with hydrogel dressings compared to 14 days with MEBO® treated group and 17days 
in the control group concluding a faster healing with the hydrogels.  
4.8. Starch:  
Starch is one of the most abundant natural polysaccharide composed of two different 
polymers, namely amylose and amylopectin. Being economical, non-toxic, 
biocompatible and biodegradable, native starch has a potential as a wound 
management material but its highly hydrophilic nature and relatively poor mechanical 
properties have limited its application. These problems can be overcome by either 
combining it with other polymer to make blend hydrogels [169] or by chemically 
modifying native starch to improve its properties for biomedical applications. 
Oxidised starch [170,171] and hydroxyethyl starch (HES) [85] are the common forms 
of modified starch used in the preparation of wound dressing. Bursali et al., 2011 
[172] prepared antimicrobial hydrogel films using potato starch-PVA complexed with 
boron using glutaraldehyde as a cross-linker. These hydrogels exhibited moderate 
antimicrobial activity (in vitro) against the tested bacterial and fungal strains, E. coli 
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(14mm ZOI), S. aureus (13mm ZOI), Pseudomonas aeruginosa (P. aeruginosa) 
(12mm ZOI) and Candida albicans (C. albicans) (14mm ZOI) thus their potential 
wound management application could be further evaluated.   
Kenawy et al., 2014 [85] synthesised biodegradable hydrogel membranes for wound 
dressing purposes using HES, PVA and ampicillin. Physical crosslinking between 
HES and PVA was achieved by consecutive (three) freeze-thaw cycles. Use of HES 
in these hydrogels enhanced the swelling ability, capability of protein (BSA) 
adsorption and thermal stability of the formulation. The release (in vitro) of ampicillin 
in phosphate buffer at 37ºC (pH 7.5) from the hydrogel formulation increased with an 
increase in HES content (0-75%). These hydrogel membranes exhibited improved 
physicochemical, mechanical, thermal, degradation and drug release properties, 
attributed to the addition of HES to PVA and have a potential in wound management 
applications.  
Timmons et al., 2008 [173], reported the effect of Aquaform® hydrogel dressing, (a 
modified starch copolymer with glycerol by Aspen Medical Europe Ltd) on the patient 
who developed moderate excoriation of the peri-anal area and multiple superficial 
breaks around the anal and vulval region due to the faecal management system to 
deal with faecal incontinence. They found that Aquaform hydrogel therapy reduced 
pain and inflammation and prevented cutaneous infection resulting in complete 
healing of all the wounds. Askina® Gel (B.Braun Medical Ltd.); Flexigran (A1 
Pharmaceuticals) and Iodosorb®, a Cadexomer iodine wound dressing 
(smith&nephew) are other commonly used starch based proprietary hydrogel 
dressings.  
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4.9. Bacterial Cellulose (BC): 
BC, a biosynthetic cellulose  is produced by several bacteria (Rhizobium, 
Agrobacterium, Alcaligenes etc.) but Gluconacetobacter xylinus, a Gram negative 
rod shaped obligate aerobe, is the best known source for BC production [174, 175]. 
BC being hydrophilic, highly pure, biocompatible, nonpyrogenic [176, 177,  178] and 
transparent material has resulted in its use for fabrication of proprietary (XCell®, 
Bioprocess®, DermafillTM, Gengiflex® and Biofill®) wound dressings with the clinical 
rationale being to facilitate autolytic debridement. Portal et al., (2009) [179] published 
their findings of a sequential paired comparison of the rate of healing (75% reduction 
in wound size set as a primary outcome) during treatment of chronic non-healing 
lower extremity ulcers with standard dressings (gauze, foams and alginates) and 
commercially available BC dressing, DermafillTM. Wounds were initially treated with 
standard dressings and only the ones that failed to heal following 60 days or more 
were selected to be treated with BC dressing. The authors reported a significant 
improvement in chronic wounds, achieving the primary outcome, with the use of 
DermafillTM dressings, in a shorter period of time confirming that BC hydrogel 
dressings enhances wound healing. 
 
Being interwoven nanofibrillar network structure, BC allows encapsulation of small 
molecules and this property has attracted vast research interest of loading different 
molecules in BC to tailor the properties of BC wound dressing [180,181,182,183]. 
Gupta et al., (2016) [3] reported the synthesis of broad spectrum antibacterial BC 
hydrogel. Whilst not antimicrobial itself, BC was loaded with two forms of silver (Ag): 
silver nitrate (AgNO3) and silver zeolites (AgZ). The authors reported prolonged in 
vitro antibacterial activity (S. aureus and P. aeruginosa) with BC-AgZ formulation 
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attributed to the double control system: first layer of control of Ag+ release from 
zeolite cage structure and a second layer of controlled release by the BC hydrogel 
itself. Contrary to this, BC-AgNO3 formulation, release of Ag
+ was only controlled by 
the BC matrix, hence less prolonged. Moreover, authors reported that the controlled 
release properties of the BC-AgZ hydrogel formulation minimises the toxicity 
associated with high topical Ag content.  
 
4.10. Carboxymethyl cellulose (CMC): 
 CMC is a semi-synthetic, water-soluble ether derivative of cellulose in which H 
atoms from the hydroxyl groups are replaced with carboxymethyl [184]. CMC can be 
crosslinked to make biocompatible and biodegradable hydrogel with high water 
uptake capacity [65,185]. Its unique properties resulted in its use in proprietary 
hydrogel dressing products like FlexiGelTM and Regranex® gel (Smith & Nephew, 
UK) and Purilon Gel®, a sodium carboxymethyl cellulose (NaCMC) based hydrogel 
dressing (Coloplast). 
Namazi et al., (2016) [186] fabricated a novel antibiotic loaded NaCMC/mesoporous 
silica nanoparticles [Mobile Composition of Matter No. 41 (MCM-41)] nanocomposite 
hydrogel with controlled release properties using citric acid as a crosslinker and 
glycerol as a plasticizer. Tetracycline was used as a broad spectrum antibiotic and 
methylene blue (cationic dye) were tested as antibacterial agents. The results 
suggested that MCM-41 in the NaCMC hydrogel enhanced the swelling properties 
and permeability of the formulation. With an increase of MCM-41 from 0-15%, the 
swelling ration doubled; water vapour and oxygen permeability increased 
dramatically. In another study, Rakhshaei and Namazi, (2017) [185] synthesised a 
tetracycline-eluting nanocomposite bioactive hydrogel dressing using NaCMC/MCM-
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41 impregnated with zinc oxide (ZnO) as an antibacterial agent. Their findings 
suggest ZnO impregnation in MCM-41 enhanced the tetracycline (TC) loading due to 
the positive charge of ZnO nanoparticles attracting TC molecules (negative charge 
above pH 7.4) to the MCM-41 surface. Also, the release of TC improved from burst 
release in pure NaCMC films within the first 3 hours to sustained release with 
CMC/ZnO-MCM-41 nanocomposite hydrogel. The final formulation exhibited strong 
antimicrobial activity (in vitro) against E. coli and S. aureus due to combined 
antimicrobial activity of ZnO (antibacterial) and prolonged release of TC (antibiotic), 
supporting the potential use of this cytocompatible hydrogel formulation in wound 
management.    
Oliveira et al., 2017 [187] fabricated PVA-sodium carboxy methyl cellulose (NaCMC) 
hydrogel containing Propolis, a resinous bees product known for its wound healing 
and antimicrobial properties, by freeze-thaw technique. The hydrogel dressing 
designed for second degree burns offered added mechanical and swelling properties 
of PVA with flexibility and high water uptake properties of NaCMC. PVA-NaCMC 
hydrogel with >15% propolis was proposed to be effective for wound healing as 
increased quantities of propolis lead to inferior mechanical properties.  
 
Table 3. Other natural and synthetic polymeric material used individually or in 
combination with other polymers for the production of hydrogel wound dressings. 
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 Source Properties Model/Case 
Study 
Results Commercial 
products 
References 
Collagen Bovine; 
Porcine; 
Avian 
Rodent 
Marine 
Natural polymer, nontoxic, biocompatible, 
biodegradable, haemostatic, support 
fibroblast growth, creates wound healing 
environment, stimulate macrophages and 
fibroblast, promote cell attachment and 
proliferation, cellular migration and tissue 
development. 
Wounds in 
diabetic mice 
[Moura et al., 
2014] 
 
Burn wounds 
in male rats 
[Oryan et al., 
2018] 
Promotes wound 
healing and 
epithelialisation  
Woun’Dres
®
 
(Coloplast) 
 
Regenecare
®
 (MPM 
Medical Inc.) 
 
 
 
188 
189  
190 
191 
192  
Gelatin Partial 
denaturation of 
bovine or porcine 
collagen 
Natural polymer, Type A and B gelatine, 
elastic, biocompatible, biodegradable, 
activate microphages, haemostatic, high 
water absorption capacity, forms thermally-
reversible hydrogels 
Wounds in 
diabetic mice 
[Yoon et al., 
2016] 
Chemokine-loaded 
gelatin hydrogel 
dressings 
promoted healing, 
enhanced re-
epithelialisation, 
neovascularisation  
HyStem
®
-C 
(BioTime Inc.) 
 
Extracel-HP 
TM 
(Glycosan 
Biosystems) 
 
 
161 
193  
194 
195 
196  
197 
Hyaluronic acid Bacterial 
fermentation;  
 
Extraction from 
animal tissues 
 
Poly anionic biological macromolecule, 
biocompatible, biodegradable, non-
immunogenic, non-thrombogenic, 
hydrophilic, antioxidant activity by reacting 
with oxygen-derived free radicals, wound 
healing activity by stimulating inflammatory 
signals and facilitate cell motility and 
proliferation. 
Wounds in 
diabetic mice 
[da Silva et 
al., 2017] 
HA hydrogels 
accelerated wound 
closure and wound 
healing. When 
incorporated with 
stem cells 
increased 
neoepidermis 
thickness observed   
Restore
®
 Hydrogels 
(Hollister 
woundcare) 
 
Regenecare
®
 HA  
 
HyStem
TM 
(BioTime 
Inc.) 
198 
199 
200 
201 
 
Dextran Leuconostoc spp 
Weissella spp 
Lactobacilli 
Bacterial polysaccharide, biocompatible, 
biodegradable, hydrophilic, stimulate wound 
healing, enhance angiogenesis, promote 
reepithelialisation 
Burn wounds 
in mice 
[Sun et al., 
2011] 
 
Wounds in 
mice 
[Alibolandi et 
al., 2017] 
Promotes wound 
healing, enables 
neovascularisation, 
promotes 
angiogenesis, 
accelerates 
epithelial 
maturation, dermal 
differentiation and 
skin regeneration 
Dextran hydrogels 
accelerate wound 
healing which was 
further improved 
by loading 
 120 
202 
203 
204 
205 
206 
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hydrogels with 
curcumin 
nanomicelles 
Glucan Cell wall of 
bacteria, yeasts, 
algae, lichens, 
plants (oats and 
barley) 
 
Polysaccharide, biocompatible, 
biodegradable, antibacterial, antiviral,  anti-
inflammatory, exhibits wound healing 
activity, immune enhancing ability, enhances 
tensile strength of scar tissue,  
26 patients 
(human 
subjects) 
with Hard-to-
heal wounds 
like leg 
ulcers, 
diabetic foot 
ulcers and 
pressure 
ulcers 
[King et al., 
2017] 
Wounds in 
diabetic mice 
[Grip et al., 
2018] 
 
Beta-glucan based 
Woulgan was very 
easy to apply and 
remove, capable of 
restarting healing 
process in a range 
of stalled wounds 
with wound size 
reduction  
Woulgan
® 
[Biotec 
Betaglucans] 
 
207 
208 
209 
210 
Guar Gum Cyamopsis 
tetragonolobus 
High molecular weight non-ionic natural 
hetero-polysaccharide, low cost, hydrophilic, 
nontoxic, biodegradable, biocompatible, FDA  
approved  
  ActivHeal
®  
(Advanced Medical 
Solutions Ltd.) 
 
3M
TM
 Tegaderm
TM
 
Hydrogel Wound 
Filler (3M Health 
Care) 
70 
211 
212 
213 
Polyurethanes Synthetic 
polymers with 
repetitive 
urethane groups 
produced by 
condensation and 
polymerisation 
methods  
 
Biocompatible, nontoxic, good strength, 
good toughness, tear resistance , abrasion 
resistance, non-allergenic, favours 
epithelialisation, allows oxygen permeability 
81 patients 
(human 
subjects) 
with acute 
and chronic 
wounds 
[Zoellner et 
al., 2007] 
 
Wounds in 
rat model 
[Bankoti et 
al., 2017] 
Enhanced 
granulation and 
epithelialisation, 
reduction in wound 
surface slough, 
pain relief, wound 
size reduction  
 
Enhanced wound 
healing, increased 
neovascularization; 
higher re-
epithelialisation, 
increased collagen 
Hydrosorb
®     
(Hartmann)
 
Hydrosorb
®  
Comfort 
(Hartmann) 
214 
215 
216 
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synthesis  
Poly(acrylic acid) Synthetic 
polymer 
produced by 
polymerisation of 
acrylic acid 
Biocompatible, biodegradable, hydrophilic, 
pH responsive polymer so can be utilised in 
producing smart hydrogels,anti-bacterial 
Wounds in 
Swiss mice 
[Champeau 
et al., 2018] 
Nitric oxide 
controlled release 
PAA hydrogels 
lead to increased 
angiogenesis, 
organised collagen 
and accelerated 
wound contraction  
 217 
218 
219 
2-acrylamido-2-
methylpropane 
sulfonic acid (AMPS) 
Commercially 
available  
or by Ritter 
reaction of 
acrylonitrile- 
isobutylene with 
sulphuric acid  
Hydrophilic, non-toxic, biocompatible,  
thermal stability, pH independent swelling 
stability, good coherency with good skin 
adhesion, easy to remove from wound 
surface, high oxygen permeability, flexible 
Porcine burn 
model 
[Boonkaew 
et al., 2014a] 
Silver nanoparticle 
loaded AMPs 
hydrogels 
efficiently 
prevented bacterial 
colonisation of 
wound during 
healing process 
 110 
115 
220 
221 
222 
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5. Conclusion and further perspectives 
Chronic wounds impose an immense socio-economic burden and if fail to respond to 
the available medical interventions, may lead to amputation, leading to severe 
physical trauma and emotional distress to patients and their families. Chronic non-
healing wounds may take several months to heal leading to multi-fold financial 
expenditure on management compared to acute wounds. Although there is a 
plethora of proprietary wound dressing products already available in the market but 
due to the increase in ageing population and incidences of chronic diseases, there is 
a critical need to continue to develop improved advanced wound dressings. 
Advanced wound care that hydrogel dressings form part of, make up around $7.1 
billion of the wound care market and to match the increasing treatment needs in this 
sector, it is growing at an annual rate of 8.3%. This review presents a brief 
description of wound healing process and current state of wound dressing products 
with the main emphasis on hydrogels as wound dressings.  Hydrogels, due to their 
unique properties, are considered as one of the most promising candidates for 
wound management as dressings.  Non-toxicity, biocompatibility, biodegradability, 
high water content, moisture-retentive property, soft texture, swelling and de-swelling 
behaviour, stimuli-responsive potential, interactive nature, controlled delivery of 
therapeutic agents and low cost are few of the many unique properties of hydrogel 
dressings. These dressings can be fabricated using several polymeric materials by 
variety of physical and chemical cross-linking techniques. Presented review also 
expands its focus on the material aspect of the natural and synthetic polymers used 
in hydrogel formation. From the evidence based on clinical case studies of the 
application of proprietary hydrogel dressing products in acute and chronic wound 
management; in vitro studies and in vivo biological models for testing new hydrogel 
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material with potential clinical applications, it can be concluded that hydrogels are 
one of the ideal candidates for wound management as dressing material. Further 
research progress leading to low cost proprietary hydrogel dressings to facilitate and 
accelerate chronic wound healing should be the focus for the future in the area of 
wound care.   
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